Holland Capital announces acquisition of HealthConnected by software company Visma 

Amsterdam, 27th of August 2025 – Investment firm Holland Capital, active in Healthcare and Technology in the Benelux and Germany, today announces the acquisition of its portfolio company HealthConnected to software company Visma.

With this acquisition, Visma further expands its healthcare portfolio. HealthConnected is a leading provider of primary care platforms, offering solutions for GP practices (HIS), out-of-hours GP services (HAPIS) and integrated and network care (NIS). Over the years, HealthConnected has proven its strength in developing valuable digital solutions for the healthcare sector. The company now joins Visma, alongside well-known healthcare providers such as Ecare, Therapieland, SureSync, Esculine and ZorgDomein. .

HealthConnected & Holland Capital

With support from Holland Capital, HealthConnected has developed into a leading platform for primary care, placing the healthcare professional at the heart of its mission. The platform’s user-friendly design helps care providers work more efficiently and spend more time with patients. Since 2020, Holland Capital has actively supported the company’s operational and strategic growth.

“I have seen HealthConnected’s journey up close and I am impressed by the team’s innovation and determination,” says Jan Frens van Giessel, Partner at Holland Capital. “With Visma as its new owner, HealthConnected has found the right partner to accelerate its growth, expand its platform and make an even bigger impact in healthcare.”

Paul Witteman, Founder and CEO of HealthConnected, looks back on a period of intensive collaboration with Holland Capital. “Collaboration is easy when everything goes according to plan, but it was precisely in the moments when this was not the case that Holland Capital truly proved its added value. That has been the foundation of a successful partnership.”

Primary care as a key link in digitalization

Visma specializes in cloud solutions that simplify and automate complex work processes, improving user experience and saving time. In healthcare, Visma’s ecosystem accelerates digitalization by improving integration and collaboration across systems.

“In our search for an innovative HIS provider, we identified HealthConnected as the perfect fit,” says Sander van de Merwe, Business Area Director Healthcare & Education at Visma. “Together, we can further scale the platform and bring strong parties under one umbrella. For example, HealthConnected and ZorgDomein can now collaborate even more effectively to address the challenges in healthcare. Boards, our joint solution for integrated and network care, already demonstrates the power of this partnership.”

Independent, with shared ambitions

HealthConnected will continue to operate independently with its own products, teams and partnerships, while benefiting from the synergies within the Visma group.

“This step allows us to innovate faster and support GPs with a platform that grows with their needs,” says Paul Witteman. “By joining Visma, we gain access to expertise in software development, security and privacy, as well as the strength of other Visma companies. At the same time, we will remain an independent organization, fully committed to openness and collaboration with other systems.”

Building a stronger healthcare ecosystem

Healthcare digitalization requires deep expertise, due to the diversity of applications, integrations and complex processes. For professionals, collaboration across the care chain is essential to support patients effectively. “Healthcare doesn’t need one all-encompassing system, but a strong ecosystem with collaboration, long-term vision and room for innovation,” says Paul Simoons, CEO of ZorgDomein, who will join the board of HealthConnected on behalf of Visma. “This acquisition allows HealthConnected and ZorgDomein to strengthen their partnership and build a seamless chain of systems. This benefits patients, healthcare providers, and creates new opportunities for our partners.”

Xilloc raises growth financing from Holland Capital

Xilloc raises growth financing from Holland Capital Geleen/Amsterdam, July 2nd 2021 - Xilloc, a leading innovator and producer of medical implants and devices, has raised growth finance for its international expansion and product development from Holland Capital....

Xilloc haalt groeifinanciering op bij investeerder Holland Capital

Xilloc haalt groeifinanciering op bij investeerder Holland Capital Geleen/Amsterdam, 2 juli 2021 – Xilloc, ontwikkelaar en producent van medische implantaten en hulpmiddelen, haalt financiering op bij Holland Capital voor internationale groeiambities. Xilloc is...

Xilloc haalt groeifinanciering op bij investeerder Holland Capital

Xilloc haalt groeifinanciering op bij investeerder Holland Capital Geleen/Amsterdam, 2 juli 2021 – Xilloc, ontwikkelaar en producent van medische implantaten en hulpmiddelen, haalt financiering op bij Holland Capital voor internationale groeiambities. Xilloc is...

Yes We Can Healthcare Group joins forces with Holland Capital

Yes We Can Healthcare Group joins forces with Holland Capital Hilvarenbeek / Amsterdam, 1st of July 2021 – Holland Capital joins forces with Yes We Can Healthcare Group (YWCHG), a mental healthcare clinic for young people between 13 and 23 with addictions and...

Yes We Can Healthcare Group bundelt krachten met Holland Capital

Yes We Can Healthcare Group bundelt krachten met Holland Capital Hilvarenbeek/Amsterdam, 1 juli 2021 – Holland Capital bundelt krachten met Yes We Can Healthcare Group (YWCHG),  een jeugdkliniek voor jongeren van 13-23 jaar met psychische problemen, verslavingen en...

Xilloc haalt groeifinanciering op bij investeerder Holland Capital

Geleen/Amsterdam, 1 juli 2021 – Xilloc, ontwikkelaar en producent van medische implantaten en hulpmiddelen, haalt financiering op bij Holland Capital voor internationale groeiambities. Xilloc is gespecialiseerd in het ontwerpen, produceren  en vermarkten vanmedische,...

Amsterdam
Krijn Taconiskade 426
1087 HW Amsterdam
+31 (0) 20 3119411

 

Düsseldorf
Königsallee 42
40212 Düsseldorf
+49 (0) 211 96290120

Contact
info@hollandcapital.nl